Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento